RNA aptamers selected against proteins can be used to modulate specific protein function. Expression of such reagents in cells and whole organisms could provide a means of dissecting and controlling molecular mechanisms in vivo. We demonstrate that Drosophila B52 protein can be specifically inhibited in vitro and in vivo by a multivalent RNA aptamer. This inhibitory aptamer RNA binds B52 avidly and inhibits B52-stimulated pre-mRNA splicing. It can be expressed in cultured cells and whole animals in a stable form that accumulates up to 10% of total mRNA. It binds B52 in vivo and suppresses all phenotypes caused by B52 overexpression. The strategies presented here should prove general in design and expression of functional and therapeutic RNAs.Multiprotein assemblies drive a variety of highly regulated biological processes. To better understand and control such processes, novel reagents are needed to modulate functions of specific proteins in cells and whole organisms. An ideal reagent would, (i) like an antibody, be made to order specifically for a particular protein, (ii) like a small organic molecule, be able to rapidly target a specific protein domain within cells, and (iii) like a conditional allele, be able to exert its effect in whole organisms, but (iv) also be targetable to specific tissues, cells, or stages of development.Although many strategies exist for inactivating genes or gene products, use of RNA aptamers (1) presents several compelling advantages. Extremely rare RNAs that have high affinity for specific proteins can be selected in vitro (SELEX) (2, 3). Genetically controlled induction of such high affinity RNA aptamers could provide a means of rapidly inactivating a specific domain of a protein and thereby assessing its primary function and mechanism of action in vivo. Alternatively, continuous expression of specific RNA aptamers after stable gene transfer could achieve a long-term alteration in the activity of a target protein. In yeast, the constitutive expression of an aptamer against RNA polymerase II caused cell growth defects under conditions in which the RNA polymerase level was artificially reduced (4). Although this study demonstrated the potential of RNA aptamers as inhibitors of protein function in vivo, several advances are needed to apply this approach to multicellular organisms.Previously, we selected and characterized RNA aptamers to B52, a regulator of RNA splicing in Drosophila melanogaster. B52, also known as SRp55, is a member of the Drosophila SR protein family, a group of nuclear proteins that are essential for pre-mRNA splicing and influence splice site choice (5, 6). B52 contains two RNA recognition motifs in its N-terminal half and a domain rich in serine-arginine dipeptide repeats in its C-terminal half (7). RNA aptamers that bind B52 with high affinity (K d ϭ 20-50 nM) and specificity were selected from a large pool of RNAs (8). The B52 binding sites (BBS) on members of this nonclonally derived family of RNA aptamers not only have a ''conserved'' consensus sequen...